Although therapeutic efficacy of 6B11 could not be demonstrated in the present study, we proved that 6B11 was effectively internalized in CEACAM5 positive cancer cells and accumulated in lysosomes, making 6B11 also a potential targeting moiety for VHH-based drug conjugates, which warrants further investigation. This evidence concerns the gene CEACAM5 and cancer.